BX Swiss TOP 30 CHF
1.268,93
PKT
-17,93
PKT
-1,39
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
08.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
08.06.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
08.06.12 | UBS buy | WestLB AG | |
08.06.12 | Logitech neutral | Sarasin Research | |
08.06.12 | Logitech hold | Vontobel Research | |
07.06.12 | Roche buy | Société Générale Group S.A. (SG) | |
06.06.12 | Holcim neutral | Goldman Sachs Group Inc. | |
06.06.12 | Holcim sell | Goldman Sachs Group Inc. | |
06.06.12 | Geberit hold | Vontobel Research | |
05.06.12 | Straumann underperform | Exane-BNP Paribas SA | |
05.06.12 | Roche outperform | Exane-BNP Paribas SA | |
05.06.12 | Novartis hold | Vontobel Research | |
04.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
04.06.12 | Roche neutral | Citigroup Corp. | |
04.06.12 | Swiss Re neutral | Exane-BNP Paribas SA | |
04.06.12 | Novartis neutral | Citigroup Corp. | |
04.06.12 | Straumann hold | Vontobel Research | |
04.06.12 | Novartis hold | Vontobel Research | |
04.06.12 | Zurich Insurance buy | Vontobel Research | |
01.06.12 | Swiss Re buy | UBS AG | |
01.06.12 | Swiss Re hold | Société Générale Group S.A. (SG) | |
01.06.12 | Kühne + Nagel International underperform | Cheuvreux SA | |
01.06.12 | Lonza hold | Vontobel Research | |
31.05.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
31.05.12 | ABB (Asea Brown Boveri) neutral | Exane-BNP Paribas SA | |
31.05.12 | Swiss Re buy | Sarasin Research | |
31.05.12 | Swiss Re add | Commerzbank Corp. & Markets | |
31.05.12 | Holcim overweight | Morgan Stanley | |
31.05.12 | Holcim equal-weight | Morgan Stanley | |
31.05.12 | Swiss Life hold | Société Générale Group S.A. (SG) | |
31.05.12 | Swiss Re buy | Vontobel Research | |
31.05.12 | Novartis buy | Deutsche Bank AG | |
30.05.12 | Roche buy | Deutsche Bank AG | |
30.05.12 | Novartis outperform | Credit Suisse Group | |
30.05.12 | Holcim outperform | Exane-BNP Paribas SA | |
29.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
29.05.12 | Novartis buy | UBS AG | |
29.05.12 | Novartis buy | UBS AG | |
29.05.12 | UBS neutral | Sarasin Research | |
29.05.12 | Richemont kaufen | Euro am Sonntag |